Home » Topics » Briefs » Other news to note

Other news to note
RSS

Celgene updates milestones of fourth quarter 2017

Jan. 31, 2018

Shire acquires license to AB Biosciences' PRIM program

Jan. 31, 2018

AbbVie presents key events from fourth quarter 2017

Jan. 31, 2018

Johnson & Johnson reviews pipeline progress of fourth quarter 2017

Jan. 30, 2018

RaQualia and ZTE Coming Biotech sign joint cooperation agreement

Jan. 29, 2018

Sanofi set to acquire Ablynx

Jan. 29, 2018

Novartis reviews regulatory and pipeline highlights of fourth quarter 2017

Jan. 26, 2018

Synpromics collaborates with UCL to develop gene therapies for blood-based disorders

Jan. 25, 2018

Astellas completes Mitobridge acquisition

Jan. 24, 2018

Skyhawk Therapeutics announces launch with USD 8 million in seed funding

Jan. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...